Skip to content

A prospective cohort study of electroacupuncture deep needling protrusion of lumbar intervertebral disc the five acupoints in the treatment of lumbar disc herniation

A prospective cohort study of electroacupuncture deep needling protrusion of lumbar intervertebral disc the five acupoints in the treatment of lumbar disc herniation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-16008777
Enrollment
Unknown
Registered
2016-07-04
Start date
2016-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Protrusion of lumbar intervertebral disc

Interventions

two:acupuncture
two:Non operative treatment

Sponsors

The Third Affiliated Hospital of Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meet the criteria for the diagnosis; 2. Age between 18 to 75 years old; 3. Course of no more than 20 years; 4. TCM syndrome type belong to blood stasis, cold dampness syndrome, hot and humid, liver and kidney deficiency license; 5. Pathological classification belongs to unilateral disc herniation or bilateral slipped disc; 6. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe lumbar disc herniation with surgical indications; 2. Complicated by severe developmental spinal stenosis or other severe malformations; 3. Weak constitution, or pregnant women, etc.; 4. Suffers from severe heart disease, high blood pressure, liver and kidney disease patients; 5. Skin damage, ulceration or skin disease; 6. Has a bleeding tendency in patients with hematologic diseases; 7. Psychiatric patients.

Design outcomes

Primary

MeasureTime frame
VAS score;JOA score;SF-36 quality of life questionnaire;Oswestry dysfunction questionnaire;

Secondary

MeasureTime frame
Patient satisfaction rating scale;Adverse event questionnaire;

Countries

China

Contacts

Public ContactZhao Jianxin

The Third Affiliated Hospital of Beijing University of Chinese Medicine

beijingzhaojianxin@163.com+86 13488876286

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026